chr1-163347798-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145697.3(NUF2):āc.984G>Cā(p.Glu328Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,608,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145697.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NUF2 | NM_145697.3 | c.984G>C | p.Glu328Asp | missense_variant | 12/14 | ENST00000271452.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NUF2 | ENST00000271452.8 | c.984G>C | p.Glu328Asp | missense_variant | 12/14 | 1 | NM_145697.3 | P1 | |
NUF2 | ENST00000367900.7 | c.984G>C | p.Glu328Asp | missense_variant | 12/14 | 1 | P1 | ||
NUF2 | ENST00000524800.5 | c.843G>C | p.Glu281Asp | missense_variant | 11/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246248Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 132952
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1455910Hom.: 0 Cov.: 30 AF XY: 0.0000180 AC XY: 13AN XY: 724008
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.984G>C (p.E328D) alteration is located in exon 12 (coding exon 11) of the NUF2 gene. This alteration results from a G to C substitution at nucleotide position 984, causing the glutamic acid (E) at amino acid position 328 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at